Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yizhongshengxue
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Yizhongshengxue is a traditional Chinese patent medicine available in capsule and tablet forms. It is primarily used as an adjuvant therapy for anemia related to cancer and other chronic diseases. Clinical studies suggest that it can improve hemoglobin levels, red blood cell counts, and quality of life in patients with tumor-related or ischemic anemia when combined with standard Western medical treatments[1][2][3][4]. The precise mechanism of action is not fully elucidated but is believed to involve hematopoietic support through multi-component herbal formulations typical of Chinese medicine.
- Brand names
- Yizhongshengxue CapsuleYizhong Shengxue Tablet
- Other names
- 益中生血胶囊 (Chinese)益中生血片 (Chinese)
Beyond the preview
Go deeper on Yizhongshengxue.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yizhongshengxue.